CompletedPhase 1NCT01590108
The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects
Studying Heritable pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Imperial College London
- Principal Investigator
- Luke Sebastian Howard, DPhilImperial College NHS Trust
- Intervention
- (Pyr1)apelin-13(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 18-90 years · MALE
- Timeline
- 2012 – 2014
Study locations (2)
- Hammersmith Hospital, Imperial College London, London, United Kingdom
- Imperial College Healthcare NHS Trust, London, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01590108 on ClinicalTrials.govOther trials for Heritable pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06850792imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNceUniversity of Sao Paulo General Hospital
- ACTIVE NOT RECRUITINGNCT06587074Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific TherapyRussian Cardiology Research and Production Center
- RECRUITINGNCT05462574Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)Vanderbilt University Medical Center
See all trials for Heritable pulmonary arterial hypertension →